Rare Cancer News & Clinical Trials » Trial

the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma

Posted: March 25th, 2020, 2:00pm GMT

Condition: Pheochromocytoma
Interventions: Drug: Dexmedetomidine; Drug: General anesthetic
Sponsor: National Cancer Institute, Egypt
Recruiting

Application of Rectus Sheath Block based-on Incision in Upper Abdominal Surgery

Posted: March 12th, 2020, 2:00pm GMT

Condition: Opioid Consumption
Interventions: Procedure: Subcostal TAP; Procedure: Modified RSB; Other: General anesthesia
Sponsor: The First Affiliated Hospital of Anhui Medical University
Recruiting

Test Up Now Education Program

Posted: March 11th, 2020, 2:00pm GMT

Condition: Colorectal Cancer Screening
Interventions: Behavioral: Community Health Advisor; Behavioral: Usual care
Sponsors: Florida A&M University; National Institute on Minority Health and Health Disparities (NIMHD)
Not yet recruiting

Permalink for 'Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial'

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

Posted: February 26th, 2020, 3:00pm GMT

Conditions: Ectomesenchymoma; Recurrent Adrenal Gland Pheochromocytoma; Recurrent Ependymoma; Recurrent Ewing Sarcoma; Recurrent Hepatoblastoma; Recurrent Langerhans Cell Histiocytosis; Recurrent Malignant Germ Cell Tumor; Recurrent Malignant Glioma; Recurrent Medulloblastoma; Recurrent Melanoma; Recurrent Neuroblastoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Osteosarcoma; Recurrent Peripheral Primitive Neuroectodermal Tumor; Recurrent Rhabdoid Tumor; Recurrent Rhabdoid Tumor of the Kidney; Recurrent Rhabdomyosarcoma; Recurrent Soft Tissue Sarcoma; Recurrent Thyroid Gland Carcinoma; Recurrent WHO Grade II Glioma; Refractory Adrenal Gland Pheochromocytoma; Refractory Ependymoma; Refractory Ewing Sarcoma; Refractory Hepatoblastoma; Refractory Langerhans Cell Histiocytosis; Refractory Malignant Germ Cell Tumor; Refractory Malignant Glioma; Refractory Medulloblastoma; Refractory Melanoma; Refractory Neuroblastoma; Refractory Non-Hodgkin Lymphoma; Refractory Osteosarcoma; Refractory Peripheral Primitive Neuroectodermal Tumor; Refractory Rhabdoid Tumor; Refractory Rhabdoid Tumor of the Kidney; Refractory Rhabdomyosarcoma; Refractory Soft Tissue Sarcoma; Refractory Thyroid Gland Carcinoma; Refractory WHO Grade II Glioma; Wilms Tumor
Intervention: Drug: Tipifarnib
Sponsor: National Cancer Institute (NCI)
Not yet recruiting

RAMPS VS SRPS for Pancreatic Body and Tail Adenocarcinoma

Posted: February 5th, 2020, 3:00pm GMT

Condition: Radical Antegrade Modular Pancreatosplenectomy
Interventions: Procedure: Radical antegrade modular pancreatosplenectomy; Procedure: Standard retrograde pancreatosplenectomy
Sponsor: Ruijin Hospital
Not yet recruiting

Biological Effect of Vitamin D in Patients With Urothelial Carcinoma

Posted: December 12th, 2019, 3:00pm GMT

Condition: Urothelial Carcinoma
Intervention: Drug: Vitamin D
Sponsors: Germans Trias i Pujol Hospital; Spanish Clinical Research Network - CAIBER; Centro Nacional de Investigaciones Oncologicas CARLOS III; Fundació Institut Germans Trias i Pujol
Recruiting

Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors

Posted: September 19th, 2019, 2:00pm GMT

Condition: Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
Intervention: Drug: ASP1948
Sponsor: Astellas Pharma Inc
Recruiting

Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth

Posted: August 15th, 2019, 2:00pm GMT

Conditions: Colon Adenocarcinoma; Colon Cancer
Intervention: Other: Exercise assessment
Sponsors: Northumbria University; York St John University; Newcastle University
Recruiting

The Master Registry of Oncology Outcomes Associated With Testing and Treatment

Posted: July 22nd, 2019, 2:00pm GMT

Conditions: Adenocarcinoma; Adenocystic Carcinoma; Anal Cancer; Appendix Cancer; Brain Tumor; Glioblastoma; Astrocytoma; Bile Duct Cancer; Cholangiocarcinoma; Bladder Cancer; Bone Cancer; Synovial Sarcoma; Chondrosarcoma; Liposarcoma; Sarcoma, Kaposi; Sarcoma,Soft Tissue; Sarcoma; Osteosarcoma; CNS Cancer; Brain Stem Neoplasms; Breast Cancer; Cervical Cancer; Colorectal Cancer; Rectal Cancer; Colon Cancer; Esophageal Cancer; Esophagus Cancer; Cancer of Colon; Pancreatic Cancer; Cancer of Pancreas; Testis Cancer; Testicular Cancer; Ureter Cancer; Renal Cell Carcinoma; Kidney Cancer; Gestational Trophoblastic Tumor; Head and Neck Neoplasms; Parotid Tumor; Larynx Cancer; Tongue Cancer; Pharynx Cancer; Salivary Gland Cancer; Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia; Multiple Myeloma; Non Hodgkin Lymphoma; Carcinoid Tumor; Lung Cancer; Neuroendocrine Tumors; Mesothelioma; Thyroid Cancer; Parathyroid Neoplasms; Adrenal Cancer; Small Bowel Cancer; Stomach Cancer; Liver Cancer; Hepatic Cancer; Melanoma; Skin Cancer; Unknown Primary Tumors; Uterine Cancer; Fallopian Tube Cancer; Ovarian Cancer; Prostate Cancer; Vaginal Cancer; Penile Cancer; Vulvar Cancer; Waldenstrom Macroglobulinemia; Cancer, Advanced; Thymus Cancer; Nasopharyngeal Carcinoma; Multiple Endocrine Neoplasia; Pheochromocytoma; Small Cell Carcinoma; Pulmonary Carcinoma
Interventions: Diagnostic Test: Testing: Genome; Diagnostic Test: Testing: Transcriptome; Diagnostic Test: Testing: Proteome; Drug: Treatment: CAR-T
Sponsor: Taproot Health
Not yet recruiting

Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy

Posted: July 15th, 2019, 2:00pm GMT

Conditions: Breast Cancer; Mastectomy; Anesthesia, Local; Narcotic Use
Interventions: Drug: regional nerve block with local anesthesia of bupivacaine with steroid; Other: Placebo regional nerveblock with normal saline
Sponsor: University of Alabama at Birmingham
Not yet recruiting

Serratus vs. Erector Spinae Fascial Plane Block for Breast and Axillary Surgery

Posted: June 7th, 2019, 2:00pm GMT

Conditions: Breast Cancer; Nerve Block; Regional Anesthesia; Neuromuscular Blockade
Interventions: Procedure: Serratus Block; Procedure: Erector spinae plane block
Sponsor: Women's College Hospital
Not yet recruiting

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer

Posted: March 5th, 2019, 3:00pm GMT

Condition: Metastatic Tumors
Interventions: Radiation: palliative radiotherapy; Radiation: Stereotactic ablative radiotherapy
Sponsors: British Columbia Cancer Agency; London Regional Cancer Program, Canada; Beatson Institute for Cancer Research, Scotland; The Alfred; Beacon Hospital, Ireland
Recruiting

A Study of ASP1951 in Subjects With Advanced Solid Tumors

Posted: January 10th, 2019, 3:00pm GMT

Condition: Advanced Solid Tumors
Interventions: Drug: ASP1951; Drug: pembrolizumab
Sponsor: Astellas Pharma Global Development, Inc.
Recruiting

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

Posted: December 15th, 2017, 3:00pm GMT

Conditions: Adrenal Gland Neoplasm; Hypertension; Bone Diseases, Metabolic; Cardiovascular Disease; Hyperinsulinemia
Intervention:
Sponsors: National Human Genome Research Institute (NHGRI); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

Posted: November 7th, 2017, 3:00pm GMT

Conditions: Genitourinary Cancer; Adrenocortical Carcinoma; Non-urothelial Bladder; Non-urothelial Upper Tract; Penile Cancer; Non-adenocarcinoma Prostate Cancer; Refractory Germ-cell
Interventions: Drug: Ipilimumab; Drug: Nivolumab
Sponsors: Dana-Farber Cancer Institute; Bristol-Myers Squibb
Recruiting

Fecal Microbiota Transplantation in Depression

Posted: September 13th, 2017, 2:00pm GMT

Condition: Major Depressive Disorder
Interventions: Drug: Fecal microbiota capsules; Drug: Placebo oral capsule
Sponsor: Psychiatric Hospital of the University of Basel
Recruiting

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Posted: July 2nd, 2017, 2:00pm GMT

Conditions: Pheochromocytoma; Paraganglioma; Neuroendocrine Tumors; Neuroendocrine Neoplasms
Interventions: Drug: Lu-177-DOTATATE; Drug: Ga-68-DOTATATE; Drug: F-18-FDG; Drug: Amino Acid solution
Sponsor: National Cancer Institute (NCI)
Recruiting

Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Posted: May 15th, 2017, 2:00pm GMT

Condition: Prostate Carcinoma
Interventions: Other: Laboratory Biomarker Analysis; Drug: Propranolol Hydrochloride; Other: Questionnaire Administration; Other: Survey Administration
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Recruiting

Renal Sympathetic Denervation From The Adventitia on Hypertension

Posted: December 30th, 2015, 3:00pm GMT

Condition: Primary Aldosteronism Due to Aldosterone Producing Adenoma
Intervention: Device: Renal Sympathetic Denervation
Sponsor: Henan Institute of Cardiovascular Epidemiology
Recruiting

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Posted: January 8th, 2008, 3:00pm GMT

Condition: Neuroblastoma
Intervention: Other: Tumor and Marrow Markers
Sponsors: Memorial Sloan Kettering Cancer Center; Southern Illinois University; Spanish National Cancer Center; St. Jude Children's Research Hospital; Washington University School of Medicine; University of Texas; Weill Medical College of Cornell University
Recruiting

Diagnosis of Pheochromocytoma

Posted: March 3rd, 2000, 3:00pm GMT

Conditions: Pheochromocytoma; Endocrine Disease; Endocrine Diseases
Interventions: Drug: ([18F]-DOPA); Drug: [68Ga]-DOTATATE; Drug: ([18F]-6F-DA)
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting

Rare Cancer News & Clinical Trials » Trial - Adrenal Cancer

Feeds

Trial - Adrenal Cancer (21 unread)